[HTML][HTML] Liver inflammation and fibrosis

Y Koyama, DA Brenner - The Journal of clinical …, 2017 - Am Soc Clin Investig
Y Koyama, DA Brenner
The Journal of clinical investigation, 2017Am Soc Clin Investig
Chronic liver inflammation leads to fibrosis and cirrhosis, which is the 12th leading cause of
death in the United States. Hepatocyte steatosis is a component of metabolic syndrome and
insulin resistance. Hepatic steatosis may be benign or progress to hepatocyte injury and the
initiation of inflammation, which activates immune cells. While Kupffer cells are the resident
macrophage in the liver, inflammatory cells such as infiltrating macrophages, T lymphocytes,
neutrophils, and DCs all contribute to liver inflammation. The inflammatory cells activate …
Chronic liver inflammation leads to fibrosis and cirrhosis, which is the 12th leading cause of death in the United States. Hepatocyte steatosis is a component of metabolic syndrome and insulin resistance. Hepatic steatosis may be benign or progress to hepatocyte injury and the initiation of inflammation, which activates immune cells. While Kupffer cells are the resident macrophage in the liver, inflammatory cells such as infiltrating macrophages, T lymphocytes, neutrophils, and DCs all contribute to liver inflammation. The inflammatory cells activate hepatic stellate cells, which are the major source of myofibroblasts in the liver. Here we review the initiation of inflammation in the liver, the liver inflammatory cells, and their crosstalk with myofibroblasts.
The Journal of Clinical Investigation